HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intratympanic gentamicin in Meniere's disease.

Abstract
Ninety-three patients with intractable Meniere's disease were treated with gentamicin (Garamycin 40 mg/ml) administered in 1 to 4 transtympanic injections. The patients were tested at frequent intervals and followed up for 2 years. Before treatment all subjects experienced moderate or severe handicap caused by Meniere's disease. Two years after the treatment, rotatory vertigo was abolished in 81% of subjects, Tumarkin attacks were cured in 60%, and work capacity was severely reduced in 10% and moderately reduced in 17% of subjects. The outcome of the caloric responses did not correlate with the outcome of the treatment. In logistic regression analysis poor outcome of treatment correlated with Tumarkin attacks (odds ratio 5.5), severity of vertigo (odds ratio 3.8) and gait disorders (odds ratio 2.9). The mean hearing level was significantly affected by the treatment (before, 59.1 dB HL; after, 67.9 dB HL). Ten treated ears became deafened. During follow-up 44 subjects were subjected to retreatment, usually after 6 months. Intratympanic gentamicin treatment is a relatively safe and effective way to treat Meniere's disease. The authors recommended starting with 2 injections and renewing the injections if relapse occurs.
AuthorsS Kaasinen, I Pyykkö, H Ishizaki, H Aalto
JournalActa oto-laryngologica (Acta Otolaryngol) Vol. 118 Issue 3 Pg. 294-8 (Jun 1998) ISSN: 0001-6489 [Print] England
PMID9655201 (Publication Type: Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Gentamicins
Topics
  • Adult
  • Aged
  • Anti-Bacterial Agents (administration & dosage, therapeutic use)
  • Audiometry, Pure-Tone
  • Chi-Square Distribution
  • Electronystagmography
  • Exercise Therapy
  • Female
  • Gentamicins (administration & dosage, therapeutic use)
  • Humans
  • Logistic Models
  • Male
  • Meniere Disease (drug therapy, physiopathology)
  • Middle Aged
  • Odds Ratio
  • Posture
  • Prospective Studies
  • Severity of Illness Index
  • Tympanic Membrane
  • Vertigo (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: